NCT00169585 - Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Prostatic HyperplasiaProstatitis

Interventions

DRUG

Levofloxacin oral tablets

Trial Locations (19)

10043

GSK Investigational Site, Orbassano (TO)

10074

GSK Investigational Site, Lanzo Torinese (TO)

10126

GSK Investigational Site, Turin

20123

GSK Investigational Site, Milan

20132

GSK Investigational Site, Milan

20142

GSK Investigational Site, Milan

23100

GSK Investigational Site, Lecco

40138

GSK Investigational Site, Bologna

50126

GSK Investigational Site, Bagno A Ripoli (FI)

70124

GSK Investigational Site, Bari

71100

GSK Investigational Site, Foggia

75100

GSK Investigational Site, Matera

80131

GSK Investigational Site, Napoli

83100

GSK Investigational Site, Avellino

95124

GSK Investigational Site, Catania

98125

GSK Investigational Site, Messina

00168

GSK Investigational Site, Rome

00189

GSK Investigational Site, Rome

07100

GSK Investigational Site, Sassari